|
The People
Management Team
Norma K. Biln, B.Sc., MBA, Chief Executive Officer
Norma Biln has brought strategic and operational execution excellence to each
position she has held along her career. Throughout her 18 years in the life
sciences she has worked along, built and led teams that have consistently
exceeded financial goals.
Norma began her career in clinical research with Pfizer Pharmaceuticals after
completing her Bachelor of Science in Physiology at McGill University. She
continued her career in several capacities in sales management, marketing and
market access with Pfizer Pharmaceuticals, Amgen and Abbott Laboratories where
she won several regional and national level awards for top performance in each
role. She later joined Stressgen Biotechnologies as Director of Corporate Market
Development and Director of Sales and Marketing for Stressgen Bioreagents. Before
her role of CEO at Augurex, Norma worked in a senior consulting capacity with
Aspreva Pharmaceuticals on Business Development, Commercial and Communications
initiatives. Norma holds a Master of Business Administration and is a member of
the Board of Directors of BioTalent Canada.
Anthony Marotta, Ph.D, Chief Scientific Officer
Dr. Marotta’s scientific creativity and knowledge have consistently created
progressive opportunities that have delivered great returns for companies that he
has been involved with.
Dr. Marotta began his career in research at Kinetek Pharmaceuticals while
completing his Ph.D. in Experimental Medicine at the University of British
Columbia. In 2004, he joined Stressgen Bioreagents as the technical services
manager where he played a key role in the development of new research products
as well as the training of lab, sales and technical staff. Dr. Marotta was
appointed to Director, Business Development when Stressgen was acquired by a
venture capital firm to later be merged with Assay Designs. During the M&A
transition Anthony was an asset to the organization from a business development,
technical, sales and operational standpoint.
|
